Venture Capital

Pioneers
Innovation-Focused
Unique Access

Venture Capital
98
Active Companies with
$1B Enterprise Value
(as of 9/30/25)
11
Years of Delivering 2x+ TVPI at
the Portfolio Company Level*

Platform Investment Criteria

Technology
Life Science
Industry
Series A/Seed
Stage
90% US
/
10% Int’l
Geographical Focus

*Total Value to Paid-In Capital (“TVPI”) represents the ratio of the current value of investments within the Fund, plus the total value of all distributions relative to a limited partner’s capital contribution.

Targeting Opportunity

Venture’s Power Law illustrates that a very small number of venture investments generate the vast majority of returns. That’s why we believe access to strong investors, early ownership and portfolio construction are critical.

The Venture Capital team, has built enduring relationships across the venture landscape, providing the team with unique access to top-tier investors. These venture capital investors are often out of reach of most limited partners. The team’s investment philosophy is predicated on their conviction in elite managers and the team’s experience identifying the next generation of top venture capital talent.


Creating Value

Talent

Accessing top-tier managers who fund what we believe are the best founders building dominant teams

Portfolio Construction

Built-in vintage and sector diversification

Evergreen & Secondary Expertise

Deep secondary underwriting expertise and sourcing access

Team Members

Paul  Gompers*
Paul Gompers*

Advisor

Matt Horten*
Matt Horten*

Managing Director

Teri Hightower
Teri Hightower

Director

Aletha Shipman
Aletha Shipman

Senior Accountant

Brooke Rempel
Brooke Rempel

Accountant

Cassie Walters
Cassie Walters

Associate, Investor Relations

Jeremy Held*
Jeremy Held*

Managing Director, Evergreen Strategies

* Investment Committee member

Portfolio

While the list below is certainly not exhaustive, these portfolio companies are representative of the top 15% of outcomes that drive 75% of total value for our investors.

Advance Intelligence
Affini-T Therapeutics
Anduril
Artbio
Artera
Cargo Therapeutics
Carmot Therapeutics
Carta
Cato Networks
Cerebras Systems
Circle
Clasp Therapeutics
Contego Medical
ClickUp
Demandbase
Eightfold AI
Eikon Therapeutics
Faire Wholesale
Forma AI
Frore Systems
Gupshup
Gusto
HilleVax
Mark43
Medable
Nasuni Corporation
Navan
Omada Health
OpenAI
Orum
Outreach
Pinecone Systems
Plaid
Primary Kids
Ramp
Route
Rubrik
SmartRecruiters
Sourcegraph
Strava
Stripe
Synnovation Therapeutics
Talkdesk
ThoughtSpot
Tools for Humanity
Ultima Genomics
Workrise
XiaoHongShu
eToro